IVIG for Hyperbilirubinemia in Newborns: Potential Benefits and Risks
Limited evidence supports the use of IVIG for hyperbilirubinemia in newborns. However, IVIG may be an option when other treatments don’t work.
Dr. Martina Mikail, PharmD was born in Egypt and raised in Pennsylvania and California. She graduated from Marshall B. Ketchum University in May 2022. Dr. Mikail is a recipent of the USPS Leadership Award and the CSHP Leadership Award, and is an active member of CSHP, ASHP, and APhA. The most rewarding part of her job is educating patients and counseling them on medications. In her free time, she likes to cook, spend time with family, and read.
Limited evidence supports the use of IVIG for hyperbilirubinemia in newborns. However, IVIG may be an option when other treatments don’t work.